| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Associations between vascular co-morbidities and depression in insulin-naive diabetes patients: the DIAZOB Primary Care Diabetes study
|
Koopmans, B.
|
|
2009
|
52 |
10 |
p. 2056-2063
|
artikel
|
| 2 |
A variant in the G6PC2/ABCB11 locus is associated with increased fasting plasma glucose, increased basal hepatic glucose production and increased insulin release after oral and intravenous glucose loads
|
Rose, C. S.
|
|
2009
|
52 |
10 |
p. 2122-2129
|
artikel
|
| 3 |
Cardiovascular risk assessment scores for people with diabetes: a systematic review
|
Chamnan, P.
|
|
2009
|
52 |
10 |
p. 2001-2014
|
artikel
|
| 4 |
Circulating β-carotene levels and type 2 diabetes—cause or effect?
|
Perry, J. R. B.
|
|
2009
|
52 |
10 |
p. 2117-2121
|
artikel
|
| 5 |
Circulating IL-18 and the risk of type 2 diabetes in women
|
Hivert, M. F.
|
|
2009
|
52 |
10 |
p. 2101-2108
|
artikel
|
| 6 |
Collateral damage: the conundrum of drug safety
|
Gale, E. A. M.
|
|
2009
|
52 |
10 |
p. 1975-1982
|
artikel
|
| 7 |
Constitutive expression of suppressor of cytokine signalling-3 in skeletal muscle leads to reduced mobility and overweight in mice
|
Lebrun, P.
|
|
2009
|
52 |
10 |
p. 2201-2212
|
artikel
|
| 8 |
Copper chelation as a potential treatment for left-ventricular hypertrophy in type 2 diabetes
|
Bakker, S. J. L.
|
|
2009
|
52 |
10 |
p. 2244
|
artikel
|
| 9 |
C-peptide is internalised in human endothelial and vascular smooth muscle cells via early endosomes
|
Luppi, P.
|
|
2009
|
52 |
10 |
p. 2218-2228
|
artikel
|
| 10 |
Diabetic retinopathy and insulin glargine
|
Chantelau, E.
|
|
2009
|
52 |
10 |
p. 2233
|
artikel
|
| 11 |
Does vitamin D status contribute to caveolin-1-mediated insulin sensitivity in skeletal muscle?
|
Boucher, B. J.
|
|
2009
|
52 |
10 |
p. 2240
|
artikel
|
| 12 |
Does vitamin D status contribute to caveolin-1-mediated insulin sensitivity in skeletal muscle? Reply to Boucher BJ [letter]
|
Oh, Y. S.
|
|
2009
|
52 |
10 |
p. 2241-2243
|
artikel
|
| 13 |
Effects of blood pressure lowering and intensive glucose control on the incidence and progression of retinopathy in patients with type 2 diabetes mellitus: a randomised controlled trial
|
Beulens, J. W. J.
|
|
2009
|
52 |
10 |
p. 2027-2036
|
artikel
|
| 14 |
Effects of glucokinase activators GKA50 and LY2121260 on proliferation and apoptosis in pancreatic INS-1 beta cells
|
Wei, P.
|
|
2009
|
52 |
10 |
p. 2142-2150
|
artikel
|
| 15 |
Glucose variability does not contribute to the development of peripheral and autonomic neuropathy in type 1 diabetes: data from the DCCT
|
Siegelaar, S. E.
|
|
2009
|
52 |
10 |
p. 2229-2232
|
artikel
|
| 16 |
Height growth velocity, islet autoimmunity and type 1 diabetes development: the Diabetes Autoimmunity Study in the Young
|
Lamb, M. M.
|
|
2009
|
52 |
10 |
p. 2064-2071
|
artikel
|
| 17 |
Impaired regulation of the TNF-α converting enzyme/tissue inhibitor of metalloproteinase 3 proteolytic system in skeletal muscle of obese type 2 diabetic patients: a new mechanism of insulin resistance in humans
|
Monroy, A.
|
|
2009
|
52 |
10 |
p. 2169-2181
|
artikel
|
| 18 |
Incidence of insulin-requiring diabetes in the US military
|
Gorham, E. D.
|
|
2009
|
52 |
10 |
p. 2087-2091
|
artikel
|
| 19 |
Insulin resistance, beta cell dysfunction and visceral adiposity as predictors of incident diabetes: the Insulin Resistance Atherosclerosis Study (IRAS) Family Study
|
Hanley, A. J. G.
|
|
2009
|
52 |
10 |
p. 2079-2086
|
artikel
|
| 20 |
Is islet autoimmunity related to insulin sensitivity or body weight in children of parents with type 1 diabetes?
|
Winkler, C.
|
|
2009
|
52 |
10 |
p. 2072-2078
|
artikel
|
| 21 |
Leptin prevents the metabolic effects of adiponectin in L6 myotubes
|
Fang, X.
|
|
2009
|
52 |
10 |
p. 2190-2200
|
artikel
|
| 22 |
Liraglutide vs insulin glargine and placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes mellitus (LEAD-5 met+SU): a randomised controlled trial
|
Russell-Jones, D.
|
|
2009
|
52 |
10 |
p. 2046-2055
|
artikel
|
| 23 |
Lise G. Heding, 1936–2008
|
Ludvigsson, J.
|
|
2009
|
52 |
10 |
p. 2245-2246
|
artikel
|
| 24 |
Long-term effect of modification of dietary protein intake on the progression of diabetic nephropathy: a randomised controlled trial
|
Koya, D.
|
|
2009
|
52 |
10 |
p. 2037-2045
|
artikel
|
| 25 |
Menopausal hormone therapy and new-onset diabetes in the French Etude Epidemiologique de Femmes de la Mutuelle Générale de l’Education Nationale (E3N) cohort
|
Lauzon-Guillain, B. de
|
|
2009
|
52 |
10 |
p. 2092-2100
|
artikel
|
| 26 |
Metabolic effects of diets differing in glycaemic index depend on age and endogenous glucose-dependent insulinotrophic polypeptide in mice
|
Isken, F.
|
|
2009
|
52 |
10 |
p. 2159-2168
|
artikel
|
| 27 |
No association of multiple type 2 diabetes loci with type 1 diabetes
|
Raj, S. M.
|
|
2009
|
52 |
10 |
p. 2109-2116
|
artikel
|
| 28 |
Novel pharmacological approaches to combat obesity and insulin resistance: targeting skeletal muscle with ‘exercise mimetics’
|
Carey, A. L.
|
|
2009
|
52 |
10 |
p. 2015-2026
|
artikel
|
| 29 |
Optimal insulin regimens in type 2 diabetes mellitus: systematic review and meta-analyses
|
Lasserson, D. S.
|
|
2009
|
52 |
10 |
p. 1990-2000
|
artikel
|
| 30 |
Perinatal survivin is essential for the establishment of pancreatic beta cell mass in mice
|
Wu, X.
|
|
2009
|
52 |
10 |
p. 2130-2141
|
artikel
|
| 31 |
Regulation of insulin gene expression by cytokines and cell–cell interactions in mouse medullary thymic epithelial cells
|
Levi, D.
|
|
2009
|
52 |
10 |
p. 2151-2158
|
artikel
|
| 32 |
Regulation of skeletal muscle sucrose, non-fermenting 1/AMP-activated protein kinase-related kinase (SNARK) by metabolic stress and diabetes
|
Rune, A.
|
|
2009
|
52 |
10 |
p. 2182-2189
|
artikel
|
| 33 |
Retinal vessel calibre and micro- and macrovascular complications in type 1 diabetes
|
Grauslund, J.
|
|
2009
|
52 |
10 |
p. 2213-2217
|
artikel
|
| 34 |
Similar progression of diabetic retinopathy with insulin glargine and neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes: a long-term, randomised, open-label study. Reply to Chantelau E [letter] and Currie CJ [letter]
|
Rosenstock, J.
|
|
2009
|
52 |
10 |
p. 2236-2239
|
artikel
|
| 35 |
The insulin glargine dilemma: an opportunity for the diabetes community?
|
Stumvoll, M.
|
|
2009
|
52 |
10 |
p. 1987-1989
|
artikel
|
| 36 |
The longest ever randomised controlled trial of insulin glargine: study design and HbA1c findings
|
Currie, C. J.
|
|
2009
|
52 |
10 |
p. 2234-2235
|
artikel
|
| 37 |
Type 1 and type 2 diabetes—chalk and cheese?
|
Owen, K. R.
|
|
2009
|
52 |
10 |
p. 1983-1986
|
artikel
|
Tijdschrift beschrijving